An experimental medication that could become the first drug derived from a marijuana plant approved in the U.S. received a boost from Food and Drug Administration staff.

The treatment’s maker, U.K. company GW Pharmaceuticals Plc, provided “substantial evidence” of the drug’s effectiveness, FDA staff said in a report released Tuesday.

The medication would treat seizures associated with two rare forms of epilepsy that typically affect children, according to the report. 

Click here to read the complete article

Anna Edney ~ Bloomberg.com

Recent News Articles

Monday April 22

MjMicro Conference

in Cannabis News

by Bruce Kennedy - Editor in Chief

MjMicro is the next level in cannabis investment. Set to take place on June 25,…

1612 hits

Tuesday April 23

Texas Lawmakers Will Vote On Marijuana Decriminalization This Week - Cannabis News

in Politics

by Bruce Kennedy - Editor in Chief

The Texas House is scheduled to vote on a bill on Thursday that would make…

975 hits

Tuesday April 23

Cannabis Nurses: An Emerging Specialization And Vital Resource For Seniors - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

Nurses who specialize in cannabis medicine are increasingly stepping in to help seniors navigate that…

1231 hits

Tuesday April 23

Hawaii founders of biodiesel firm unveil their own green new deal: Hemp - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

Earth Day blessing fetes Maui’s first state-licensed industrial hemp farm.

1458 hits

Tuesday April 23

When It Comes to Cannabis Workplace Injuries, the Eyes Have It - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

In Colorado, one of the state’s largest worker’s compensation insurance firms has released some unique…

1791 hits